Top Ten Tips Palliative Care Clinicians Should Know About Delivering Specialty-Aligned Palliative Care

Leiter, Richard E.; Bischoff, Kara; Carey, Elise C.; Gelfand, Samantha L.; Iyer, Anand S; Jain, Nelia; Kramer, Neha M.; Lally, Kate; Landzberg, Michael J.; Lever, Natasha M; Newport, Kristina; O’Donnell, Arden; Patel, Arpan; Sciacca, Kate; Snaman, Jennifer M.; Tulsky, James A.; Rosa, William E.; Lakin, Joshua R.

doi:10.1089/jpm.2023.0116

Cited by 5 publications

(2 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: What Are the Clinical Conditions And Potential Risks Of The ...mentioning

confidence: 99%

“…Interdisciplinary communication and collaboration among all involved disciplines, including palliative care, general practitioners, and geriatric oncology, are crucial to ensuring that patients receive the most appropriate care for their unique circumstances. [69][70][71] Patients with hematological malignancies carry a significant burden of illness, often receiving more aggressive end-of-life treatments and experiencing a high level of symptom distress. Despite this, they tend to underutilize palliative care, especially those with leukemia.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

To Treat or Not to Treat? Dilemmas when Deciding on Antineoplastic Treatment in Patients With Far Advanced Cancers

et al. 2023

View full text Add to dashboard Cite

Patients with advanced cancers and their oncologists are often faced with difficult treatment decisions, especially when there are borderline situations of expected benefit or increased risk of complications. In this narrative review, we will explore the decision-making process for patients with advanced cancers and provide insights on how to approach this complex task, while didactically dividing the oncologist’s assessments according to a mnemonic rule of the ABCDE of therapeutic decision-making. Part A (advanced cancer) recalls that the rule is to be used specifically for advanced cancers. Parts B (potential benefits) and C (clinical conditions and risks) represents the traditional risk vs benefit scale. In Part D, we discuss ways to identify and understand patients’ desires, values, preferences, and beliefs. The prognostic estimation, from Part E, may function as an “adjust” for the antineoplastic treatment decision-making. Treatment decisions need to be conducted by skilled oncologists, in a patient-centered care, aiming to promote valuable oncology with lower rates of aggressive care.

show abstract

Section: What Are the Clinical Conditions And Potential Risks Of The ...mentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%